Go to the list of all blogs
Alicia's Avatar
published in Blogs
Mar 19, 2026
Red Cat Holdings, Inc. (RCAT) Stock Falls Over -16% on Post‑Earnings Jitters and Profit‑Taking

Red Cat Holdings, Inc. (RCAT) Stock Falls Over -16% on Post‑Earnings Jitters and Profit‑Taking

Red Cat Holdings, Inc. (RCAT), a defense‑focused drone manufacturer and unmanned systems provider, saw its stock tumble more than 16% today. The move comes immediately after the company reported record quarterly and full‑year revenue but another steep net loss, prompting investors to lock in large gains from a 200%‑plus 12‑month rally and reassess the balance between growth and ongoing financial risk.

Key Takeaways

  • RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.

  • The company reported Q4 2025 revenue of US$26.2 million, up 1,985% from US$1.3 million a year earlier, and FY 2025 revenue of about US$89.8 million, up roughly 161% year over year — but still posted a full‑year net loss of US$72.1 million.

  • Q3 and Q4 earnings missed analyst EPS expectations (Q3 EPS of –US$0.17 vs. –US$0.14 estimate; Q4 continuing‑operations loss widening), underscoring that scale‑up and program wins have not yet translated into profitability.

  • Analysts remain constructive on the defense‑demand story, with an average 12‑month target around US$18–19 and “Outperform”‑type recommendations, but valuation models such as GuruFocus’ GF Value warn that the current price still embeds very aggressive assumptions.

  • Recent volatility — including double‑digit up‑moves ahead of earnings and multi‑day declines tied to partnership changes, high operating expenses and liquidity concerns — has made RCAT a high‑beta proxy for speculative defense and drone enthusiasm, magnifying today’s reaction.

On a day when a speculative defense‑tech name like RCAT swings more than 16%, many traders lean on AI‑driven tools to understand what is really driving the tape. Systems similar to Tickeron’s continuously scan for earnings releases, pre‑market gaps, and outsized volume, and then compare RCAT’s move with historical post‑earnings reactions and sector peers in unmanned systems and defense. By analyzing order‑flow, volatility spikes, and breaks through key technical levels (such as the stock’s recent slide back toward the mid‑teens after failing to hold above US$17–18), these AI models can help distinguish plain profit‑taking from a deeper loss of confidence in the company’s financial trajectory. For active traders, AI‑powered screeners, pattern‑recognition engines, and real‑time risk dashboards provide a structured framework for deciding whether to buy into the selloff, trim exposure, or wait for signs of stabilization.

Fundamentally, Red Cat has just delivered the strongest top‑line performance in its history. Q4 2025 revenue came in at US$26.24 million, slightly ahead of the roughly US$23.9 million consensus, and up nearly 2,000% from US$1.3 million in Q4 2024 as the company ramped deliveries of its military‑grade small tactical drones. For the full fiscal year, revenue rose to about US$89.8 million, a 161% increase from US$34.4 million in 2024, reflecting larger defense and government contracts and the transition into mass production of platforms like the Teal 2. Management has highlighted strong demand from U.S. and allied defense customers amid new Pentagon “drone dominance” initiatives and U.S. National Defense Authorization Act provisions (like Section 1709) that restrict foreign‑made components, a backdrop that clearly supports Red Cat’s U.S.‑built, secure‑supply‑chain positioning.

However, the flip side of that rapid growth has been persistent and widening losses. Despite the revenue surge, Red Cat reported a Q4 net loss of roughly US$19.7 million and a full‑year net loss of about US$72.1 million, compared with a US$53.5 million loss in 2024. Operating expenses more than doubled, to roughly US$67.9 million for 2025, driven by higher R&D, production ramp‑up, overhead and stock‑based compensation. Q3 2025 results already signaled the strain: the company posted an EPS loss of –US$0.17, missing the –US$0.14 consensus by US$0.03, even as revenue topped estimates. That pattern — revenue beats paired with deeper‑than‑expected losses — has made investors question how quickly Red Cat can convert its defense pipeline into sustainable profitability.

The balance sheet and valuation picture further complicate the story. Earlier commentary noted that Red Cat ended a recent quarter with total debt and liabilities around US$32.7 million and equity of roughly US$253 million, while operating cash flow remained negative, highlighting the need for continued external funding or improved cash generation. At recent prices around US$15–17, the stock implies a market capitalization near US$1.9–2.0 billion, translating into a rich price‑to‑sales and negative price‑to‑earnings profile for a company still in the red. GuruFocus’ GF Value model, for example, estimates a one‑year fair value in the low single digits — around US$2.50 — suggesting that the current price could be more than 80% above what historical multiples and projected performance would justify. While many analysts and narrative‑driven investors disagree with such a pessimistic fair‑value estimate, its existence underscores how polarized views on RCAT’s valuation have become.

Recent trading behavior shows just how sensitive the stock now is to news and positioning. Over the last few weeks, RCAT has experienced multiple sessions with intraday moves greater than 7–10% in both directions. Reports highlighted a sharp selloff earlier in March after the dissolution of a DJI‑related partnership and concerns over high operating expenses and liquidity, followed by surges of 9–10% on days when investors piled in ahead of earnings, betting on a positive surprise. MarketBeat and other sources note that, even after today’s drop, the shares are still up more than 200% over the past year, with a 90%+ year‑to‑date return as of mid‑March — exactly the kind of profile where any sign of ongoing losses or financing risk can trigger aggressive profit‑taking.

Looking ahead, the key question for investors is whether today’s 16‑plus‑percent decline marks a buying opportunity in a fast‑growing defense player or a warning that expectations have run too far ahead of fundamentals. Bulls will point to the massive ramp in revenue, a defense environment increasingly favoring U.S.‑built drones, and a growing production base that could support operating leverage as volumes scale. Bears will emphasize continued large net losses, high operating costs, liquidity concerns, and valuation metrics that remain demanding even after today’s selloff. Until Red Cat can demonstrate a clear path to breakeven and consistent cash‑flow generation while sustaining revenue growth, the stock is likely to remain highly volatile — and days like today will continue to test investors’ conviction.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: RCAT

Contributor

Alicia's AvatarAlicia|Beginner

RCAT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RCAT turned positive on July 31, 2026. Looking at past instances where RCAT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on RCAT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RCAT moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RCAT crossed bullishly above the 50-day moving average on August 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RCAT moved out of overbought territory on August 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where RCAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RCAT broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RCAT entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.118) is normal, around the industry mean (7.037). P/E Ratio (0.000) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (16.026) is also within normal values, averaging (20.174).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RCAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.